Simultaneous determination of apolipoprotein AIV T347S and Q360H genotypes using a heteroduplex generator [2]

Atherosclerosis

Volumn 165, Issue 2, 2002, Pages 385-388

  Li, L K ^a   Humphries, S E ^a,b   Wood, N ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; CHOLESTEROL ESTER; DNA; GLYCOPROTEIN; HETERODUPLEX; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; NUCLEOTIDE; TRIACYLGLYCEROL; APOLIPOPROTEIN A; APOLIPOPROTEIN A-IV; ISOPROTEIN;

ANALYTIC METHOD; ATHEROSCLEROSIS; CATABOLISM; ELECTROPHORESIS; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HEPATOMA CELL; HUMAN; IN VITRO STUDY; INTESTINE CELL; KNOCKOUT MOUSE; LETTER; MEDICAL LITERATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; PUBLICATION; TRANSGENIC ANIMAL; CORONARY ARTERY DISEASE; GENETICS; HETERODUPLEX ANALYSIS; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

APOLIPOPROTEINS A; BASE SEQUENCE; CORONARY DISEASE; GENOTYPE; HETERODUPLEX ANALYSIS; HUMANS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS;

EID: 0036890379     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00118-1     Document Type: Letter

References (22)

1. Kronenberg F., Stuhlinger M., Trenkwalder E., Geethanjali F.S., Pachinger O., von Eckardstein A., Dieplinger H. Low apolipoprotein AIV plasma concentrations in men with coronary artery disease. J. Am. Coll. Cardiol. 36:(3):2000;751-757.
2. Tso P., Liu M., Kalogeris T.J., Thomson A.B. The role of apolipoprotein A-IV in the regulation of food intake. Annu. Rev. Nutr. 21:2001;231-254.
3. Bolla M.K., Wood N., Humphries S.E. Rapid determination of apolipoprotein E (APOE) genotype using a heteroduplex generator. J. Lipid Res. 40:1999;2340-2345.
4. Duverger N., Tremp G., Caillaud J.M., et al. Protection against atherogenesis in mice mediated by human apolipoprotein AIV. Science. 273:1996;966-968.
5. Cohen R.D., Castellani L.W., Qiao J.H., Van Lenten B.J., Lusis A.J., Reue K. Reduced aortic lesions and elevated high-density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein AIV. J. Clin. Invest. 99:1997;1906-1916.
6. Weinstock P.H., Bisgaier C.L., Hayek T., et al. Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behaviour in apolipoprotein AIV knockout mice. J. Lipid Res. 38:1997;1782-1794.
7. Pennacchio L.A., Olivier M., Hubacek J.A., et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 294:(5540):2001;169-173.
8. Fisher RM, Burke H, Nicaud V, Ehnholm C, Humphries SE, on behalf of the EARS Group. Effect of variation in the apo AIV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II. J Lipid Res 1999;40;287-94.
9. Menzel H.J., Kovary P.M., Assman G. Apolipoprotein AIV polymorphism in man. Hum. Genet. 62:1982;349-352.
10. Boerwinkle E., Visvikis S., Chan L. Two polymorphisms for amino acid substitutions in the APOA4 gene. Nucleic Acids Res. 18:1990;4966.
11. Saha N., Wang G., Vasisht S., Kamboh M.I. Influence of two apo A4 polymorphisms at codons 347 and 360 on non-fasting plasma lipoprotein-lipids and apolipoproteins in Asian Indians. Atherosclerosis. 131:1997;249-255.
12. Jansen S., Lopez-Miranda J., Salas J., et al. Effect of 347-serine mutation in apolipoprotein AIV on plasma LDL cholesterol response to dietary fat. Arterioscler. Thromb. Vasc. Biol. 17:1997;1532-1568.
13. Jansen S., Lopez-Miranda J., Ordovas J.M., et al. Effect of 360His mutation in apolipoprotein AIV on plasma HDL-cholesterol response to dietary fat. J. Lipid Res. 38:1997;1995-2002.
14. Rader D.J., Schäfer J., Lohse P., et al. Rapid in vivo transport and catabolism of human apolipoprotein AIV-1 and slower catabolism of the apoAIV-2 isoprotein. J. Clin. Invest. 92:1993;1009-1017.
15. Weinberg R.B., Jordan M.K., Steinmetz A. Distinctive structure and function of human apolipoprotein variant apoAIV-2. J. Biol. Chem. 265:1990;18372-18378.
16. Rewers M., Kamboh M.I., Hoag S., Shetterly S.M., Ferrell R.E., Hamman R.F. ApoAIV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis Valley Diabetes Study. Diabetes. 43:1994;1485-1489.
17. Campos H., López Miranda J., Rodríguez C., Albajar M., Schaefer E.J., Ordovás J.M. Urbanization elicits a more atherogenic lipoprotein profile in carriers of the apolipoprotein AIV-2 allele than in AIV-1 homozygotes. Arterioscler. Thromb. Vasc. Biol. 17:1997;1074-1081.
18. von Eckardstein A., Heinrich J., Funke H., et al. Glutamine/histidine polymorphism in apo AIV affects plasma concentrations of lipoprotein(a) and fibrin split products in coronary heart disease patients. Arterioscler. Thromb. 13:(2):1993;240-246.
19. Groenendijk M., De Bruin T.W., Dallinga-Thie G.M. Two polymorphisms in the apo AIV gene and familial combined hyperlipidemia. Atherosclerosis. 158:(2):2001;369-376.
20. Merched A., Xia Y., Papadopoulou A., Siest G., Visvikis S. Apolipoprotein AIV codon 360 mutation increases with human aging and is not associated with Alzheimer's disease. Neurosci. Lett. 13:(242(2)):1998;117-119.
21. Wood N., Bidwell J. Genetic screening and testing by induced heteroduplex formation. Electrophoresis. 17:1996;247-254.
22. Karathanasis S.K., Yunis I. Structure, evolution and tissue-specific synthesis of human apolipoprotein AIV. Biochemistry. 25:1986;3962-3970.